NEPHROS INC (NEPH) has a current P/E ratio of 364.0.
NEPHROS INC (NEPH) has a 5-year average return on invested capital (ROIC) of -29.9%. This is below average and may indicate limited pricing power.
NEPHROS INC (NEPH) has a market capitalization of $39M. It is classified as a small-cap stock.
NEPHROS INC (NEPH) does not currently pay a regular dividend.
NEPHROS INC (NEPH) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
NEPHROS INC (NEPH) reported annual revenue of $19 million in its most recent fiscal year, based on SEC EDGAR filings.
NEPHROS INC (NEPH) has a net profit margin of 6.4%. This is a modest margin.
NEPHROS INC (NEPH) generated $2 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Item 1. Business We are a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, we sell water filtration products. Our medical water filters, mostly classified as ultrafilters, are used primarily by hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. Because our ultrafilters capture contaminants as small as 0.005 microns in size, they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. In commercial markets, we manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 19M | 19M | 14M | 14M | 10.0M | 10M |
| Net Income | 776K | 1.2M | 74K | -1.6M | -7.4M | -4.1M |
| EPS | $0.07 | $0.11 | $0.01 | $-0.15 | $-0.73 | $-0.41 |
| Free Cash Flow | 0 | 1.6M | -547K | 752K | -3.4M | -1.5M |
| ROIC | 10.0% | 19.3% | 0.1% | -30.5% | -105.8% | -32.7% |
| Gross Margin | 59.9% | 61.9% | 61.6% | 59.0% | 47.4% | 55.1% |
| Debt/Equity | 0.00 | 0.10 | 0.00 | 0.01 | 0.23 | 0.09 |
| Dividends/Share | $0.00 | $0.00 | - | - | - | - |
| Operating Income | 677K | 1.1M | 6K | -1.6M | -4.3M | -3.3M |
| Operating Margin | 3.5% | 6.1% | 0.0% | -11.2% | -43.5% | -31.8% |
| ROE | 7.3% | 12.7% | 0.9% | -22.6% | -85.4% | -33.9% |
| Shares Outstanding | 11M | 11M | 7M | 11M | 10M | 10M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | N/A | 1.9M | 2.3M | 3.8M | 5.7M | 10M | 8.6M | 10M | 10.0M | 14M | 14M | 19M | 19M |
| Gross Margin | N/A | 54.5% | 55.8% | 60.2% | 56.3% | 58.9% | 57.4% | 55.1% | 47.4% | 59.0% | 61.6% | 61.9% | 59.9% |
| R&D | 781K | 826K | 1.1M | 1.0M | 1.5M | 3.1M | 2.8M | 1.5M | 1.3M | 873K | 906K | 1.3M | 1.4M |
| SG&A | 2.9M | 3.4M | 2.9M | 3.3M | 4.5M | 6.1M | 6.5M | 7.2M | 7.6M | 8.9M | 7.7M | 9.0M | 9.3M |
| EBIT | -2.7M | -3.4M | -2.9M | -2.2M | -3.0M | -3.2M | -4.3M | -3.3M | -4.3M | -1.6M | 6K | 1.1M | 677K |
| Op. Margin | N/A | -176.0% | -123.7% | -58.4% | -53.0% | -30.5% | -49.9% | -31.8% | -43.5% | -11.2% | 0.0% | 6.1% | 3.5% |
| Net Income | -7.4M | -3.2M | -3.0M | -809K | -3.4M | -3.4M | -4.8M | -4.1M | -7.4M | -1.6M | 74K | 1.2M | 776K |
| Net Margin | N/A | -162.6% | -130.7% | -21.2% | -59.8% | -33.1% | -55.7% | -40.2% | -74.0% | -11.1% | 0.5% | 6.4% | 4.1% |
| Non-Recurring | 0 | 0 | 0 | 0 | -10K | 0 | 0 | 0 | 1.0M | 0 | 5K | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -62.6% | -68.1% | -184.3% | -102.8% | -164.3% | -92.5% | -56.6% | -32.7% | -105.8% | -30.5% | 0.1% | 19.3% | 10.0% |
| ROE | 156.8% | 75.8% | 303.7% | -61.8% | -118.4% | -80.7% | -55.4% | -33.9% | -85.4% | -22.6% | 0.9% | 12.7% | 7.3% |
| ROA | -235.6% | -86.1% | -91.2% | -21.1% | -43.8% | -30.8% | -31.6% | -22.7% | -51.5% | -13.8% | 0.6% | 9.6% | 5.6% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -2.5M | -3.8M | -2.1M | -77K | -3.7M | -2.3M | -6.9M | -1.4M | -3.2M | 827K | -492K | 1.6M | -348K |
| Free Cash Flow | -2.5M | -3.8M | -2.2M | -77K | -3.7M | -2.3M | -7.1M | -1.5M | -3.4M | 752K | -547K | 1.6M | 0 |
| Owner Earnings | -3.0M | -4.3M | -2.7M | -1.1M | -4.8M | -3.8M | -7.9M | -2.9M | -4.4M | -439K | -780K | 1.2M | -1.7M |
| CapEx | 0 | 13K | 45K | 0 | 0 | 14K | 239K | 36K | 137K | 75K | 55K | 0 | 0 |
| Maint. CapEx | 6K | 1K | 19K | 218K | 163K | 186K | 192K | 192K | 218K | 214K | 135K | 140K | 1.1M |
| Growth CapEx | N/A | 12K | 26K | N/A | N/A | 0 | 47K | 0 | 0 | 0 | 0 | N/A | 0 |
| D&A | 6K | 1K | 19K | 218K | 163K | 186K | 192K | 192K | 218K | 214K | 135K | 140K | 1.1M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 9.1% | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | 0.0% | 0.0% | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 530K | 489K | 551K | 772K | 985K | 1.3M | 779K | 1.3M | 982K | 1.1M | 153K | 296K | 280K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | 288K | N/A | 563K | -240K | -2.3M | -2.0M | -6.6M | -6.0M | -2.4M | -4.2M | -3.7M | -4.3M | -4.0M |
| Cash & Equiv. | 1.3M | 1.2M | 275K | 2.2M | 4.6M | 4.2M | 8.2M | 7.0M | 3.6M | 4.3M | 3.8M | 5.4M | 4.0M |
| Long-Term Debt | 1.6M | N/A | 838K | 954K | 1.0M | 824K | 593K | 343K | 71K | N/A | 17K | 11K | 10K |
| Debt/Equity | -0.28 | -0.49 | 1.26 | 1.00 | 0.59 | 0.47 | 0.14 | 0.09 | 0.23 | 0.01 | 0.00 | 0.10 | 0.00 |
| Interest Coverage | -5.5 | -81.5 | -16.7 | -7.4 | -17.5 | -16.2 | -38.9 | -79.3 | -216.8 | -796.5 | 3.0 | 1146.0 | 677.0 |
| Equity | -5.7M | -2.7M | 667K | 1.9M | 3.8M | 4.7M | 13M | 12M | 5.6M | 8.4M | 8.6M | 10M | 11M |
| Total Assets | 3.4M | 4.0M | 2.7M | 5.0M | 11M | 12M | 19M | 18M | 11M | 12M | 11M | 14M | 14M |
| Total Liabilities | 9.1M | 1.3M | 2.0M | 3.0M | 3.8M | 3.9M | 2.9M | 2.9M | 2.1M | 3.5M | 2.6M | 3.4M | 3.1M |
| Intangibles | N/A | N/A | 2.3M | 2.3M | 590K | 548K | 506K | 465K | 423K | 381K | 349K | 318K | 310K |
| Retained Earnings | -114M | -117M | -120M | -121M | -124M | -127M | -132M | -136M | -143M | -144M | -144M | -143M | -143M |
| Working Capital | 437K | 1.5M | 369K | 1.9M | 5.5M | 5.9M | 14M | 11M | 6.8M | 6.3M | 6.7M | 8.5M | 9.0M |
| Current Assets | 1.7M | 2.5M | 1.3M | 3.8M | 8.2M | 8.3M | 15M | 14M | 8.3M | 8.4M | 8.3M | 11M | 11M |
| Current Liabilities | 1.2M | 959K | 895K | 1.9M | 2.7M | 2.4M | 1.3M | 2.4M | 1.4M | 2.1M | 1.6M | 2.8M | 2.5M |
| Per Share Data | |||||||||||||
| EPS | -2.48 | -0.72 | -0.48 | -0.16 | -4.00 | -0.45 | -0.52 | -0.41 | -0.73 | -0.15 | 0.01 | 0.11 | 0.07 |
| Owner EPS | -1.02 | -0.98 | -0.42 | -0.21 | -5.66 | -0.50 | -0.86 | -0.29 | -0.44 | -0.04 | -0.11 | 0.11 | -0.16 |
| Book Value | -1.91 | -0.61 | 0.11 | 0.39 | 4.47 | 0.62 | 1.37 | 1.17 | 0.55 | 0.80 | 1.16 | 0.94 | 0.99 |
| Cash Flow/Share | -0.84 | -0.87 | -0.33 | -0.02 | -4.31 | -0.30 | -0.75 | -0.14 | -0.32 | 0.08 | -0.07 | 0.15 | 0.17 |
| Dividends/Share | N/A | N/A | 0.00 | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 |
| Shares Out. | 3.0M | 4.4M | 6.3M | 5.1M | 0.9M | 7.6M | 9.2M | 10.0M | 10.1M | 10.5M | 7.4M | 10.9M | 10.8M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 149.0 | N/A | 50.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 48.7 | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 52.4 |
| Price/Book | N/A | 2.9 | N/A | N/A | N/A | 16.5 | 5.9 | 5.4 | 2.0 | 4.4 | 1.8 | N/A | 3.7 |
| Price/Sales | N/A | 10.5 | N/A | N/A | N/A | 4.7 | 8.2 | 8.3 | 2.6 | 1.1 | 1.7 | N/A | 2.1 |
| FCF Yield | -13.1% | -49.5% | N/A | N/A | N/A | -3.0% | -9.7% | -2.3% | -30.3% | 2.1% | -3.5% | N/A | N/A |
| Market Cap | 19M | 7.7M | 0 | 0 | 0 | 77M | 73M | 63M | 11M | 37M | 16M | 0 | 39M |
| Avg. Price | 6.76 | 5.25 | 0.00 | 0.00 | 0.00 | 6.41 | 7.62 | 8.08 | 2.54 | 1.56 | 2.21 | 0.00 | 3.64 |
| Year-End Price | 7.20 | 1.98 | 0.00 | 0.00 | 0.00 | 10.14 | 8.00 | 6.07 | 1.10 | 3.49 | 1.49 | 0.00 | 3.64 |
NEPHROS INC passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 57.0%. At current prices, the estimated annualized return to fair value is -10.6%.
NEPHROS INC (NEPH) has a debt-to-equity ratio of 0.10. This indicates a conservatively financed balance sheet.
NEPHROS INC (NEPH) reported earnings per share (EPS) of $0.11 in its most recent fiscal year.
NEPHROS INC (NEPH) has a return on equity (ROE) of 12.7%. This indicates moderate shareholder returns.
NEPHROS INC (NEPH) has a 5-year average gross margin of 57.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for NEPHROS INC (NEPH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NEPHROS INC (NEPH) has a book value per share of $0.94, based on its most recent annual SEC filing.